| Titolo |
Pubblicato in |
Anno |
| Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex |
ACTA NEUROPATHOLOGICA |
2024 |
| Membranes and Synaptosomes Used to Investigate Synaptic GABAergic Currents in Epileptic Patients |
MEMBRANES |
2024 |
| Selective modulation of epileptic tissue by an adenosine A3 receptor-activating drug |
BRITISH JOURNAL OF PHARMACOLOGY |
2024 |
| WONOEP appraisal: The role of glial cells in focal malformations associated with early onset epilepsies |
EPILEPSIA |
2024 |
| Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network |
JOURNAL OF THE NEUROLOGICAL SCIENCES |
2024 |
| Intranasal administration of KYCCSRK peptide rescues brain insulin signaling activation and reduces Alzheimer’s disease-like neuropathology in a mouse model for Down syndrome |
ANTIOXIDANTS |
2023 |
| Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models |
INFLAMMATION AND REGENERATION |
2023 |
| Traditional and Innovative Anti-seizure Medications Targeting Key Physiopathological Mechanisms: Focus on Neurodevelopment and Neurodegeneration |
CURRENT NEUROPHARMACOLOGY |
2023 |
| Plasma biomarker profile and clinical correlations in adult patients with tuberous sclerosis complex |
NEUROLOGY |
2023 |
| Olfactory impairment in autoimmune encephalitis: another piece of the puzzle |
JOURNAL OF NEUROLOGY |
2022 |
| A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies |
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY |
2022 |
| Lipid mediator n-3 docosapentaenoic acid-derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G-protein-coupled receptor |
THE FASEB JOURNAL |
2022 |
| Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity |
BIOMEDICINES |
2022 |
| Classical and Unexpected Effects of Ultra-Micronized {PEA} in Neuromuscular Function |
BIOMOLECULES |
2022 |
| Unexpected Effect of IL-1beta on the Function of GABAA Receptors in Pediatric Focal Cortical Dysplasia |
BRAIN SCIENCES |
2022 |
| Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study |
FRONTIERS IN PHARMACOLOGY |
2022 |
| GABAA receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1β |
SCIENTIFIC REPORTS |
2022 |
| Late-onset seizures and epilepsy: Electroclinical features suggestive of autoimmune etiology. |
FRONTIERS IN NEUROLOGY |
2022 |
| GABAergic neurotransmission in human tissues is modulated by cannabidiol |
LIFE |
2022 |
| Dissecting the molecular determinants of GABAA receptors current rundown, a hallmark of refractory human epilepsy |
BRAIN SCIENCES |
2021 |
